These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

762 related items for PubMed ID: 23407627

  • 1. Rate, causes, and impact on patient outcome of implantable device complications requiring surgical revision: large population survey from two centres in Italy.
    Palmisano P, Accogli M, Zaccaria M, Luzzi G, Nacci F, Anaclerio M, Favale S.
    Europace; 2013 Apr; 15(4):531-40. PubMed ID: 23407627
    [Abstract] [Full Text] [Related]

  • 2. REPLACE DARE (Death After Replacement Evaluation) score: determinants of all-cause mortality after implantable device replacement or upgrade from the REPLACE registry.
    Chung MK, Holcomb RG, Mittal S, Steinberg JS, Gleva MJ, Mela T, Uslan DZ, Mitchell K, Poole JE, REPLACE Investigators.
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1048-56. PubMed ID: 25221331
    [Abstract] [Full Text] [Related]

  • 3. Predictors of 30-day and 1-year mortality after transvenous lead extraction: a single-centre experience.
    Deckx S, Marynissen T, Rega F, Ector J, Nuyens D, Heidbuchel H, Willems R.
    Europace; 2014 Aug; 16(8):1218-25. PubMed ID: 24569572
    [Abstract] [Full Text] [Related]

  • 4. Predictors of short-term complications after implantable cardioverter-defibrillator replacement: results from the Ontario ICD Database.
    Krahn AD, Lee DS, Birnie D, Healey JS, Crystal E, Dorian P, Simpson CS, Khaykin Y, Cameron D, Janmohamed A, Yee R, Austin PC, Chen Z, Hardy J, Tu JV, Ontario ICD Database Investigators.
    Circ Arrhythm Electrophysiol; 2011 Apr; 4(2):136-42. PubMed ID: 21325209
    [Abstract] [Full Text] [Related]

  • 5. Sex differences in implantable cardioverter-defibrillator implantation indications and outcomes: lessons from the Nationwide Israeli-ICD Registry.
    Amit G, Suleiman M, Konstantino Y, Luria D, Kazatsker M, Chetboun I, Haim M, Gavrielov-Yusim N, Goldenberg I, Glikson M, Israeli Working Group on Pacing and Electrophysiology.
    Europace; 2014 Aug; 16(8):1175-80. PubMed ID: 24554524
    [Abstract] [Full Text] [Related]

  • 6. PR interval identifies clinical response in patients with non-left bundle branch block: a Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy substudy.
    Kutyifa V, Stockburger M, Daubert JP, Holmqvist F, Olshansky B, Schuger C, Klein H, Goldenberg I, Brenyo A, McNitt S, Merkely B, Zareba W, Moss AJ.
    Circ Arrhythm Electrophysiol; 2014 Aug; 7(4):645-51. PubMed ID: 24963007
    [Abstract] [Full Text] [Related]

  • 7. Incremental benefit of cardiac resynchronisation therapy with versus without a defibrillator.
    Martens P, Verbrugge FH, Nijst P, Dupont M, Nuyens D, Herendael HV, Rivero-Ayerza M, Tang WH, Mullens W.
    Heart; 2017 Dec; 103(24):1977-1984. PubMed ID: 28716973
    [Abstract] [Full Text] [Related]

  • 8. Device-related infection among patients with pacemakers and implantable defibrillators: incidence, risk factors, and consequences.
    Nery PB, Fernandes R, Nair GM, Sumner GL, Ribas CS, Menon SM, Wang X, Krahn AD, Morillo CA, Connolly SJ, Healey JS.
    J Cardiovasc Electrophysiol; 2010 Jul; 21(7):786-90. PubMed ID: 20102431
    [Abstract] [Full Text] [Related]

  • 9. Implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy: efficacy and complications of the therapy in long-term follow-up.
    Syska P, Przybylski A, Chojnowska L, Lewandowski M, Sterliński M, Maciag A, Gepner K, Pytkowski M, Kowalik I, Maczyńska-Mazuruk R, Ruzyłło W, Szwed H.
    J Cardiovasc Electrophysiol; 2010 Aug 01; 21(8):883-9. PubMed ID: 20132378
    [Abstract] [Full Text] [Related]

  • 10. Lead extraction: The road to successful cardiac resynchronization therapy.
    Maciąg A, Syska P, Sterliński M, Przybylski A, Sitkowska E, Oręziak A, Bilińska M, Kuśmierczyk M, Szwed H.
    Cardiol J; 2015 Aug 01; 22(2):188-93. PubMed ID: 25299498
    [Abstract] [Full Text] [Related]

  • 11. Increased late complex device infections are determined by cardiac resynchronization therapy-defibrillator infection.
    Unsworth JD, Zaidi A, Hargreaves MR.
    Europace; 2015 Nov 01; 17(11):1708-11. PubMed ID: 25883081
    [Abstract] [Full Text] [Related]

  • 12. Complications of permanent cardiac pacing in patients with persistent left superior vena cava.
    Polewczyk A, Kutarski A, Czekajska-Chehab E, Adamczyk P, Boczar K, Polewczyk M, Janion M.
    Cardiol J; 2014 Nov 01; 21(2):128-37. PubMed ID: 24526508
    [Abstract] [Full Text] [Related]

  • 13. Battery longevity in cardiac resynchronization therapy implantable cardioverter defibrillators.
    Alam MB, Munir MB, Rattan R, Flanigan S, Adelstein E, Jain S, Saba S.
    Europace; 2014 Feb 01; 16(2):246-51. PubMed ID: 24099864
    [Abstract] [Full Text] [Related]

  • 14. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry.
    Poole JE, Gleva MJ, Mela T, Chung MK, Uslan DZ, Borge R, Gottipaty V, Shinn T, Dan D, Feldman LA, Seide H, Winston SA, Gallagher JJ, Langberg JJ, Mitchell K, Holcomb R, REPLACE Registry Investigators.
    Circulation; 2010 Oct 19; 122(16):1553-61. PubMed ID: 20921437
    [Abstract] [Full Text] [Related]

  • 15. Brain natriuretic peptide and cardiac resynchronization therapy in patients with mildly symptomatic heart failure.
    Brenyo A, Barsheshet A, Rao M, Huang DT, Zareba W, McNitt S, Hall WJ, Peterson DR, Solomon SD, Moss AJ, Goldenberg I.
    Circ Heart Fail; 2013 Sep 01; 6(5):998-1004. PubMed ID: 23801020
    [Abstract] [Full Text] [Related]

  • 16. Survival in Women Versus Men Following Implantation of Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices in a Large, Nationwide Cohort.
    Varma N, Mittal S, Prillinger JB, Snell J, Dalal N, Piccini JP.
    J Am Heart Assoc; 2017 May 10; 6(5):. PubMed ID: 28490521
    [Abstract] [Full Text] [Related]

  • 17. Complications in recipients of cardioverter-defibrillator or cardiac resynchronization therapy: Insights from Silesian Center Defibrillator registry.
    Tajstra M, Gadula-Gacek E, Kurek A, Adamowicz-Czoch E, Olszowski D, Ostręga M, Ciślak A, Pyka Ł, Hawranek M, Lekston A, Poloński L, Gąsior M.
    Cardiol J; 2017 May 10; 24(5):515-522. PubMed ID: 27734455
    [Abstract] [Full Text] [Related]

  • 18. Multipolar pacing by cardiac resynchronization therapy with a defibrillators treatment in type 2 diabetes mellitus failing heart patients: impact on responders rate, and clinical outcomes.
    Sardu C, Barbieri M, Santamaria M, Giordano V, Sacra C, Paolisso P, Spirito A, Marfella R, Paolisso G, Rizzo MR.
    Cardiovasc Diabetol; 2017 Jun 09; 16(1):75. PubMed ID: 28599667
    [Abstract] [Full Text] [Related]

  • 19. A single-centre experience concerning the safety of Sprint Fidelis defibrillator lead extraction at the time of pulse generator replacement or in case of evidence of lead failure.
    Da Costa A, Da Cruz C, Romeyer-Bouchard C, Abdellaoui L, Nadrouss A, Bisch L, Chometon F, Afif Z, Gate-Martinet A, Combier M, Isaaz K.
    Arch Cardiovasc Dis; 2012 Apr 09; 105(4):203-10. PubMed ID: 22633294
    [Abstract] [Full Text] [Related]

  • 20. Risk of hematoma complications after device implant in the clopidogrel era.
    Kutinsky IB, Jarandilla R, Jewett M, Haines DE.
    Circ Arrhythm Electrophysiol; 2010 Aug 09; 3(4):312-8. PubMed ID: 20558847
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.